SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002475
Filing Date
2024-03-05
Accepted
2024-03-05 16:06:00
Documents
101
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20231231x10k.htm   iXBRL 10-K 3041452
2 EX-10.9 rigl-20231231xex10d9.htm EX-10.9 143024
3 EX-23.1 rigl-20231231xex23d1.htm EX-23.1 14685
4 EX-31.1 rigl-20231231xex31d1.htm EX-31.1 14909
5 EX-31.2 rigl-20231231xex31d2.htm EX-31.2 14993
6 EX-32.1 rigl-20231231xex32d1.htm EX-32.1 10082
7 EX-97 rigl-20231231xex97.htm EX-97 44705
8 GRAPHIC rigl-20231231x10k003.jpg GRAPHIC 76954
9 GRAPHIC rigl-20231231x10k004.jpg GRAPHIC 28560
  Complete submission text file 0001558370-24-002475.txt   12498399

Data Files

Seq Description Document Type Size
10 EX-101.SCH rigl-20231231.xsd EX-101.SCH 77845
11 EX-101.CAL rigl-20231231_cal.xml EX-101.CAL 76006
12 EX-101.DEF rigl-20231231_def.xml EX-101.DEF 284793
13 EX-101.LAB rigl-20231231_lab.xml EX-101.LAB 678547
14 EX-101.PRE rigl-20231231_pre.xml EX-101.PRE 497329
103 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20231231x10k_htm.xml XML 2224001
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 24720288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)